May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Demonstration of high gain phosphorylation in vivo using ectopic expression of cone S–opsin in transgenic mouse rods
Author Affiliations & Notes
  • G. Shi
    Biochemistry & Molecular Biology, Zilkha Neurogenetic Institute, Los Angeles, CA
  • K. Motamedchaboki
    Biochemistry & Molecular Biology, Zilkha Neurogenetic Institute, Los Angeles, CA
  • A. Roca
    Biochemistry & Molecular Biology, Zilkha Neurogenetic Institute, Los Angeles, CA
  • R. Langen
    Biochemistry & Molecular Biology, Zilkha Neurogenetic Institute, Los Angeles, CA
  • J. Chen
    Biochemistry & Molecular Biology, Zilkha Neurogenetic Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  G. Shi, None; K. Motamedchaboki, None; A. Roca, None; R. Langen, None; J. Chen, None.
  • Footnotes
    Support  NIH Grant EY12155
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1267. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Shi, K. Motamedchaboki, A. Roca, R. Langen, J. Chen; Demonstration of high gain phosphorylation in vivo using ectopic expression of cone S–opsin in transgenic mouse rods . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1267.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purposes: To establish whether light–activated rhodopsin (R*) leads to phosphorylation of dark rhodopsin (R) in intact rod photoreceptor cells. In vitro experiments using isolated rod outer segments suggest that low levels of R* can lead to phosphorylation of dark rhodopsin (Binder BM, et al. J. Biol. Chem. 1996; 271). This has been termed "high gain" phosphorylation, reflecting the high stoichiometry of incorporated phosphate beyond the level expected if only R* were phosphorylated. Whether this process occurs in vivo is uncertain due to difficulties in distinguishing R* from R biochemically. Methods: We generated transgenic mice that expressed mouse cone S–opsin in the rhodopsin–/– and rhodopsin +/– backgrounds. Ectopically expressed S–opsin localized to the rod outer segment, whether in the presence or absence of endogenous rhodopsin. S–opsin is a spectrally distinct visual pigment with an absorption maxima near 360 nm. The large separation in spectral sensitivity between S–opsin and rhodopsin at long wavelengths (>515 nm) allows for specific stimulation of rhodopsin using yellow light (>515 nm). Transgenic S–opsin is functional in rod cells, as indicated by electrophysiological measurements (electroretinogram and suction electrode recordings). Intact retinas were isolated and exposed to 360 nm or >515 nm light, and phosphorylation of rhodopsin and S–opsin was monitored using LC–MS (modified from Kennedy MJ, et al. Neuron 2001; 31). Results: We found that S–opsin, when expressed in the absence of rhodopsin, was phosphorylated following exposure to 360 nm light, but was not phosphorylated after exposure to >515 nm light. However, when S–opsin was co–expressed with rhodopsin, it became phosphorylated at multiple sites when intact retinas were exposed to >515 nm light. Conclusions: Our results support the presence of high gain phosphorylation in vivo. This may occur if activated rhodopsin kinase phosphorylates nearby R via transphosphorylation. High gain phosphorylation may play a role in some aspects of light adaptation, since phosphorylated rhodopsin exhibits lowered efficiency in activating transducin.

Keywords: phosphorylation • opsins • transgenics/knock–outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×